Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
miR-145-5p has been reported to be downregulated and described functioning as a tumor suppressive gene in colorectal cancer (CRC), yet its detailed regulatory function and mechanism in malignant progression of the disease have not been thoroughly understood. In our study, miR-145-5p and
rhomboid domain containing 1
(
RHBDD1
) in CRC tissues and cells were examined by qRT-PCR and western blot. MTT, colony formation, wound healing, Transwell invasion, and flow cytometry assays were performed to evaluate the malignant phenotypes of CRC cells. Xenograft tumor, qRT-PCR, and western blot assays were applied to validate the roles and mechanism of miR-145-5p in CRC in vivo. The interaction between miR-145-5p and
RHBDD1
was investigated by luciferase reporter assay and western blot. The changes of the EGFR/Raf/
MEK
/ERK pathway were detected by western blot. We found miR-145-5p was lowly expressed and low miR-145-5p predicted poor prognosis in CRC, while
RHBDD1
was greatly enhanced in CRC cells and tissues.
RHBDD1
silencing resulted in inhibiting cell proliferative, invasive, and migratory potentials as well as elevating apoptotic ones in CRC cells. miR-145-5p was inversely related with
RHBDD1
expression in CRC tissues. miR-145-5p was found to directly bind to
RHBDD1
and restrained its expression in CRC cells. miR-145-5p overexpression repressed CRC cell proliferation, invasion, migration and induced apoptosis, and these effects were reversed by
RHBDD1
upregulation. Moreover, in CRC xenograft tumor, its growth was impeded by miR-145-5p via suppressing
RHBDD1
. Furthermore, miR-145-5p inhibited the expression of EGFR, p-
MEK1
/2 and p-ERK1/2, in vitro and in vivo by targeting
RHBDD1
. In conclusion, our study revealed that miR-145-5p overexpression inhibited tumorigenesis in CRC by downregulating
RHBDD1
via suppressing the EGFR-associated signaling pathway (EGFR/Raf/
MEK
/ERK cascades).
...
PMID:miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway. 3169 35